Literature DB >> 7671874

Parathyroid function in cardiac transplant patients: evaluation during physical exercise.

G Brandenberger1, B Schnedecker, K Spiegel, B Mettauer, B Geny, J Sacrez, E Lampert, J Lonsdorfer.   

Abstract

The survival rate of heart transplant patients has increased considerably since the development of new immunosuppressive drugs. In the long term, however, cardiac transplantation results in a high incidence of osteoporosis which represents a major functional handicap. To examine whether patients in the early stages have impaired phosphocalcic metabolism, intact parathyroid hormone (PTH 1-84), native osteocalcin, ionized Ca++ and pH were measured at rest and during muscular exercises a dynamic test used to override circadian and ultradian PTH variations. A group of 12 patients receiving the usual immunosuppressive therapy, which is mainly an association of cyclosporin and prednisolone, and 8 sedentary control subjects performed a square-wave endurance test at the same relative intensity for 30 min. No patient had previous bone disease and the period since transplantation was 12.2 +/- 2.7 months. For the transplant patients, initial PTH concentrations and responses to exercise were higher (P < 0.01) compared to the control subjects with a dramatic increase after 10 min of recovery. From higher (P < 0.001) resting concentrations, osteocalcin further increased during exercise (P < 0.01) in the heart transplant group but not in the control subjects. In both groups pH showed the same time-course with a rapid fall during exercise (P < 0.05) and Ca++ concentrations increased during the exercise period. (P < 0.01 for patients; P < 0.05 for controls) with a significant fall in both groups after 10 min of recovery (P < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7671874     DOI: 10.1007/bf00618490

Source DB:  PubMed          Journal:  Eur J Appl Physiol Occup Physiol        ISSN: 0301-5548


  27 in total

Review 1.  New insights into endocrine disturbances of chronic renal failure.

Authors:  F Schaefer; O Mehls; E Ritz
Journal:  Miner Electrolyte Metab       Date:  1992

2.  Differences in basal and postexercise osteocalcin levels in athletic and nonathletic humans.

Authors:  S Nishiyama; S Tomoeda; T Ohta; A Higuchi; I Matsuda
Journal:  Calcif Tissue Int       Date:  1988-09       Impact factor: 4.333

3.  The calciotropic hormone response to changes in serum calcium during exercise in female long distance runners.

Authors:  S K Grimston; K E Tanguay; C M Gundberg; D A Hanley
Journal:  J Clin Endocrinol Metab       Date:  1993-04       Impact factor: 5.958

4.  Combined treatment with cyclosporin A and cortisone acetate minimizes the adverse bone effects of either agent alone.

Authors:  C Movsowitz; M Schlosberg; S Epstein; F Ismail; M Fallon; S Thomas
Journal:  J Orthop Res       Date:  1990-09       Impact factor: 3.494

5.  Effects of cyclosporin A on rat osteoblasts (ROS 17/2.8 cells) in vitro.

Authors:  L K McCauley; T J Rosol; C C Capen
Journal:  Calcif Tissue Int       Date:  1992-10       Impact factor: 4.333

6.  Cardiovascular responses of heart transplant patients to exercise training.

Authors:  S Keteyian; R Shepard; J Ehrman; F Fedel; C Glick; K Rhoads; T B Levine
Journal:  J Appl Physiol (1985)       Date:  1991-06

7.  Cardiorespiratory responses to exercise training after orthotopic cardiac transplantation.

Authors:  T Kavanagh; M H Yacoub; D J Mertens; J Kennedy; R B Campbell; P Sawyer
Journal:  Circulation       Date:  1988-01       Impact factor: 29.690

8.  Pulse amplitude and frequency modulation of parathyroid hormone in plasma.

Authors:  H M Harms; U Kaptaina; W R Külpmann; G Brabant; R D Hesch
Journal:  J Clin Endocrinol Metab       Date:  1989-10       Impact factor: 5.958

9.  Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.

Authors:  D Bunjes; C Hardt; M Röllinghoff; H Wagner
Journal:  Eur J Immunol       Date:  1981-08       Impact factor: 5.532

10.  The course of biochemical parameters of bone turnover during treatment with corticosteroids.

Authors:  M F Prummel; W M Wiersinga; P Lips; G T Sanders; H P Sauerwein
Journal:  J Clin Endocrinol Metab       Date:  1991-02       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.